You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 16, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
Lina Gao1, Li Sun1, Weihua Li1
1Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Immunohistochemistry (IHC) shows 100% sensitivity for detecting ROS1 gene fusions in non-small cell lung cancer (NSCLC), making it a valuable initial screening tool. Next-generation sequencing (NGS) is recommended for confirming strong IHC results and identifying fusion partners.
Area of Science:
07:59Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018